NuVina – Terms of Sale

1. Introduction & Definitions

1.1 Trading Entity

The NuVina service is operated by 535 Maryhill Road Ltd (Company No. SC761365), registered at 125 West Regent Street, Glasgow, G2 2SD. NuVina is a trading name of 535 Maryhill Road Ltd.

535 Maryhill Road Ltd also trades as North Park Pharmacy (GPhC Registration: 1126488), 535 Maryhill Road, Glasgow, G20 7UJ.

1.2 Definitions

• "We", "Us", "Our": 535 Maryhill Road Ltd (trading as NuVina)
• "You", "Patient": the individual receiving treatment
• "Treatment Programme": the clinically supervised GLP-1 weight-management protocol (including medication, monitoring and oversight)
• "GLP-1 Medications": prescription-only medicines including (but not limited to) Mounjaro (tirzepatide) and Wegovy (semaglutide)
• "Clinical Team": GMC-registered doctors and GPhC-registered Independent Prescribing Pharmacists
• "Mandatory Consultation": the required Independent Prescribing Pharmacist consultation prior to treatment commencement if deemed necessary

1.3 Agreement to Terms

By purchasing services from NuVina, you confirm that you have read, understood and agree to be bound by these Terms. If you do not agree, do not proceed.

Contact: Nuvina@NorthParkPharmacy.onmicrosoft.com

2. Independent Prescribing Pharmacist Consultation

2.1 Consultation Requirement

If it is deemed necessary the patient must complete a consultation with our Independent Prescribing Pharmacist before commencing treatment.

2.2 Consultation Process

The consultation includes:

• comprehensive review of your medical history and eligibility;
• discussion of contraindications, drug interactions and safety considerations;
• explanation of treatment protocols, dose-escalation schedules and expected outcomes;
• discussion of potential side effects and when to seek medical attention;
• establishment of monitoring requirements and ongoing support procedures.

2.3 Consultation Outcome

Following consultation, our Independent Prescribing Pharmacist will determine whether treatment is clinically appropriate. We reserve the absolute right to refuse treatment if it is deemed unsuitable or unsafe. No refund of consultation fees (if applicable) will be provided if treatment is declined on clinical grounds.

3. Eligibility and Medical Assessment

3.1 Eligibility Requirements

To be eligible for treatment through NuVina, you must:

• be at least 18 years of age;
• be a resident of the United Kingdom with a valid UK address;
• complete our eligibility assessment truthfully and accurately;
• attend the Independent Prescribing Pharmacist consultation if required;
• provide proof of identity if requested;
• have a BMI that meets clinical prescribing guidelines;
• have no contraindications to GLP-1 medications.

3.2 Truthful Disclosure Obligation (Warranty & Indemnity)

You have an absolute obligation to provide complete, truthful and accurate information about your medical history, current medicines (including OTC and supplements), allergies and health conditions. Our clinical team relies entirely on the information you provide to make prescribing decisions. Any omission, misrepresentation or false information may result in immediate termination of treatment without refund. We accept no liability for adverse outcomes arising from inaccurate or incomplete information provided by you.

Your Warranty & Indemnity. You warrant that all information you provide is complete and accurate and that you will promptly update us before any further supply if anything changes. To the extent permitted by law, you agree to indemnify us and North Park Pharmacy for losses reasonably and directly arising from your breach of this warranty or using a product contrary to instructions, except where caused by our or our clinicians' negligence.

4. Treatment Programme and Patient Obligations

4.1 Treatment Protocol Adherence

GLP-1 medications must be used strictly as prescribed. By accepting treatment, you agree to:

• follow the prescribed dose-escalation schedule (you must not increase doses faster than prescribed);
• attend all required monitoring appointments (consultations or check-ins);
• report side effects promptly (failure to report may result in suspension);
• use medication solely for your own use (sharing or selling is prohibited and may be unlawful);
• store medication correctly and keep it out of reach of others;
• dispose of sharps safely using the provided sharps bin.

4.2 Personalised Dose Titration

GLP-1 therapy requires gradual dose increases to minimise side effects and optimise safety. Your treatment plan includes:

• initial starting dose to assess tolerance;
• structured escalation over weeks/months;
• clinical review points before each increase;
• maximum treatment duration typically 12–24 months unless clinically indicated otherwise.

You must not deviate from this schedule without clinical authorisation.

4.3 Treatment Duration and Review

Weight-management treatment with GLP-1 medications is intended as a time-limited intervention:

• Initial treatment period: typically 12–24 months;
• Regular reviews: every 3–6 months;
• Treatment goals: defined weight-loss targets will be set.

We reserve the right to discontinue treatment if weight-loss targets are not met within reasonable timeframes, treatment is no longer clinically indicated, you experience contraindications or adverse effects, or you fail to comply with monitoring requirements.

4A. Inherent Medical Risks & Patient Responsibility

All GLP-1 medications carry known, disclosed risks, including serious side effects. By agreeing to treatment, you acknowledge and accept that:

• (a) no medicine is risk-free;
• (b) the prescribing decision is made by the clinician using their professional judgment based on the information you provide;
• (c) you will read and follow the Patient Information Leaflet and dosing/storage instructions; and
• (d) you will stop treatment and seek urgent medical help if serious symptoms occur.

This clause does not limit liability for death or personal injury caused by our negligence.

5. Your Right to Discontinue Treatment

You may discontinue treatment at any time by notifying Nuvina@NorthParkPharmacy.onmicrosoft.com.

Refunds:

• Before first dispensing: full refund if the prescription has not yet been dispensed;
• After dispensing: no refund for dispensed medication (for safety reasons);
• Subscriptions: provide at least 48 hours' notice before the next scheduled dispatch to avoid the next charge.

6. Abuse Prevention and Prohibitions

6.1 Prohibited Conduct

Strictly prohibited and grounds for immediate termination:

• misuse of medication;
• sharing or selling medication (illegal under the Medicines Act 1968);
• creating multiple accounts to obtain additional medication;
• providing false information to obtain a prescription;
• dose stacking or hoarding to escalate doses;
• purely cosmetic/off-label use without medical indication;
• simultaneously obtaining the same medication from other providers.

6.2 Detection and Consequences

We employ monitoring systems to detect abuse. If abuse is suspected or detected:

• treatment will be suspended immediately;
• no refunds will be provided;
• accounts may be permanently closed;
• we may report concerns to regulators (GMC, GPhC, MHRA) or law enforcement.

6.3 Clinical Safeguards

To prevent misuse we may require: mandatory Independent Prescribing Pharmacist consultations, regular clinical reviews, prescription quantity limits aligned with dose schedules, identity verification, cross-checking against pharmacy databases where appropriate, and GP verification of medical history where appropriate.

7. Clinical Oversight and Monitoring

7.1 Dual Clinical Review

All prescriptions are subject to review by:

• an Independent Prescribing Pharmacist (GPhC registered); and
• a GMC-registered doctor where clinically indicated.

7.2 Ongoing Monitoring Requirements

You agree to participate in ongoing monitoring including: periodic weight and BMI assessments; side-effect reporting; clinical check-ins (phone, video or questionnaire); blood tests if clinically indicated; and communication with your GP (with your consent). Failure to comply may result in suspension of treatment.

8. Prescription and Dispensing

8.1 Prescription Approval

Prescriptions are issued at the discretion of our clinical team. We aim to review requests within 24 hours. If your request is declined, you will be notified with reasons and no charge will be made. You may request re-assessment if circumstances change.

8.2 Dispensing and Delivery

Approved prescriptions are dispensed by North Park Pharmacy (GPhC: 1126488). Medication is delivered via tracked, discreet postal service to your registered UK address only.

8.3 Repeat Prescriptions

Repeat prescriptions are based on clinical assessment. Typical parameters:

• monthly supply;
• review before dose increases;
• prescription validity typically 6–12 months (requiring new assessment on expiry).

8.4 Prescription Quantity Limits

Professional standards and legal restrictions limit quantities supplied. You will not usually receive more than one month's supply every 28–30 days unless clinically justified.

9. Payment, Returns and Refunds

9.1 Payment Terms

Payment is taken when the prescription is approved and passed to the pharmacy for dispensing. Subscription payments are taken 48 hours before scheduled dispatch.

9.2 No Returns Policy (Safety Requirement)

For safety and regulatory reasons, we cannot accept returns of prescription medications. This is because we cannot verify integrity once medicines leave our control, GLP-1 medications may be temperature-sensitive, and regulations prohibit re-dispensing returned medicines.

9.3 Refund Eligibility

Refunds are provided only if:

• before dispensing (full refund);
• wrong item dispensed by us (replacement or refund);
• damaged on arrival (reasonable evidence required);
• delivery failure: delayed >7 days beyond the expected date.

No refunds are provided for change of mind after dispensing, side effects or perceived ineffectiveness, voluntary termination after dispensing, or termination due to non-compliance.

9.4 Cooling-Off Rights (Legal Basis)

Under the Consumer Contracts (Information, Cancellation and Additional Charges) Regulations 2013, prescription-only medicines are exempt from the 14-day cooling-off right once dispensing has begun, for reasons of health protection.

10. Our Right to Refuse or Terminate Service

10.1 Right to Refuse Treatment

We may refuse treatment or decline a prescription for clinical or operational reasons including: clinical unsuitability or contraindications; insufficient or unreliable medical information; inability to verify identity; suspected abuse or misuse; non-compliance with protocols; failure to attend Mandatory Consultation; supply constraints.

10.2 Right to Terminate Treatment

We may terminate your treatment immediately without notice if you breach these Terms, provide false or misleading information, are suspected of misuse, fail to comply with clinical instructions, treatment becomes clinically inappropriate, you fail to respond to requests for information, or adverse effects require discontinuation. No refunds are provided where termination is due to your breach.

10A. Delivery & Custody Responsibility

Once medication is delivered to the postal address you provide, risk transfers to you. You are responsible for preventing access by others (including children and pets), for safe storage (including any cold-chain requirements) and for safe disposal of sharps.

11. Liability and Disclaimers

11.1 Exclusions (where lawful)

We do not accept liability for damages, losses or adverse outcomes resulting from:

• your failure to provide accurate or complete medical information;
• your failure to follow prescribed protocols or instructions;
• your failure to report side effects or changes in health status;
• your misuse, abuse or sharing of medication;
• your use of medication contrary to clinical advice or the Patient Information Leaflet;
• side effects that are inherent and disclosed risks of GLP-1 therapy where we and our clinicians have exercised reasonable care.

11.2 Not a GP Replacement

Our service does not replace your NHS GP or regular healthcare provider. You must maintain GP registration, inform your GP of treatment (we facilitate this with your consent) and consult your GP for other health concerns.

11.3 Medical Emergency

In an emergency, call 999 or attend A&E immediately. Do not rely on our service for urgent medical advice.

11.4 Legal Limits

Nothing in these Terms excludes or limits liability for death or personal injury caused by our negligence, for fraud or fraudulent misrepresentation, or for any liability that cannot be excluded under UK law.

12. Data Protection and Record-Keeping

12.1 Patient Records

We are legally required to maintain patient records for a minimum of 8 years following your last order or prescription. Records may include your personal details, medical history, consultation notes, prescriptions, treatment history, clinical assessments, and correspondence. See our Privacy Policy for full details.

12.2 Information Sharing

We may share your information with: your NHS GP (with your consent); North Park Pharmacy (for dispensing); our Clinical Team; regulators where required by law; and law enforcement where illegal activity is suspected.

13. Regulatory Compliance

13.1 Framework

We operate under the Medicines Act 1968, Human Medicines Regulations 2012, GPhC Standards, GMC Good Medical Practice, UK GDPR/Data Protection Act 2018, and applicable Scottish healthcare regulation.

(If any care is delivered under CQC-regulated services in England, the relevant CQC requirements will also apply and will be identified on request.)

13.2 Professional Registration

Clinical services are provided by:

• GPhC-registered Independent Prescribing Pharmacists;
• GMC-registered doctors;
• Dispensing by North Park Pharmacy (GPhC: 1126488).

You can verify registrations via the GPhC and GMC public registers.

14. Complaints and Dispute Resolution

14.1 Making a Complaint

Please see our Complaints Procedure page or contact Nuvina@NorthParkPharmacy.onmicrosoft.com.

14.2 Regulatory Complaints

You may also complain to:

• General Pharmaceutical Council, 25 Canada Square, London E14 5LQ;
• General Medical Council, 3 Hardman Street, Manchester M3 3AW;
• (If applicable) the Care Quality Commission for any England-regulated clinical services.

15. General Provisions

15.1 Entire Agreement

These Terms of Sale, together with our Website Terms of Use and Privacy Policy, constitute the entire agreement between you and 535 Maryhill Road Ltd.

15.2 Severability

If any provision is held to be invalid or unenforceable, the remaining provisions remain in full force and effect.

15.3 Modification of Terms

We may update these Terms at any time. Updated versions will be posted on our website with a revised "Last Updated" date. Continued use constitutes acceptance.

15.4 Governing Law & Jurisdiction

These Terms are governed by the laws of Scotland. Any disputes will be subject to the exclusive jurisdiction of the Scottish courts.

15.5 Company Information

535 Maryhill Road Ltd — trading as NuVina and North Park Pharmacy
Company No: SC761365 • VAT No: 487933236
Registered Office: 125 West Regent Street, Glasgow, G2 2SD
Pharmacy Address: 535 Maryhill Road, Glasgow, G20 7UJ
GPhC Registration: 1126488